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Abstract
Background: Systematic management of patients suffering high-risk symptoms is essential in emergency medical
services. Patients with chest pain receive algorithm-based work-up and treatment. Though dyspnea is recognized as
an independent predictor of mortality, no generally accepted prehospital treatment algorithm exists and this may
affect outcome. The objective of this study was to compare mortality in patients suspected of myocardial infarction
(MI) presenting with dyspnea versus chest pain in the ambulance.
Methods: Follow-up study in patients undergoing electrocardiogram-based telemedical triage because of suspected
MI in an ambulance in the Central Denmark Region from 1 June 2008 to 1 January 2013. Primary outcome was 30-day
mortality. Secondary outcomes were 4-year mortality and mortality rates in subgroups of patients with and without a
confirmed MI. Absolute risk differences adjusted for comorbidity, age, systolic blood pressure and heart rate were
calculated by a generalized linear regression model.
Results: Of 17,398 patients, 12,230 (70 %) suffered from chest pain, 1464 (8 %) from dyspnea, 3540 (20 %) from other
symptoms and 164 (1 %) from cardiac arrest. Among patients with dyspnea, 30-day mortality was 13 % (CI 12–15) and
4-year mortality was 50 % (CI 47–54) compared to 2.9 % (CI 2.6-3.2) and 20 % (CI 19–21) in patients with chest pain.
MI was confirmed in 121 (8.3 %) patients with dyspnea and in 2319 (19 %) with chest pain. Patients with
dyspnea and confirmed MI had a 30-day and 4-year mortality of 21 % (CI 15–30) and 60 % (CI 50–70)
compared to 5.0 % (CI 4.2-5.8) and 23 % (CI 21–25) in patients with chest pain and confirmed MI. Adjusting
for age, comorbidity, systolic blood pressure and heart rate did not change these patterns.
Conclusion: Patients suspected of MI presenting with dyspnea have significantly higher short- and long-term
mortality than patients with chest pain irrespective of a confirmed MI diagnosis. Future studies should examine if
supplementary prehospital diagnostics can improve triage, facilitate early therapy and improve outcome in patients
presenting with dyspnea.
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Background
In emergency medical services (EMS), a systematic ap-
proach to patients suffering high-risk symptoms is essen-
tial. Systematic guidelines for prehospital management of
chest pain were developed more than a decade ago and
prehospital management plays an increasingly important
role in cardiac arrest guidelines [1, 2]. Timely prehospital
diagnostics and early primary percutaneous coronary
intervention or fibrinolysis in ST-elevation myocardial
infarction (STEMI) have contributed significantly to a
reduced mortality in myocardial infarction (MI) [3, 4]. In
out-of-hospital cardiac arrest (OHCA), a combination of
layperson cardiopulmonary resuscitation, early defibrilla-
tion, improved skills among EMS personnel and advanced
life support has improved outcome [5]. For patients with
dyspnea, however, we have no commonly accepted guide-
lines for prehospital management. This is a paradox, since
dyspnea is recognized as an independent predictor of
mortality [6, 7]. In Denmark, a prehospital electrocardio-
gram (ECG) based telemedical diagnosis of STEMI is
sought not only in patients with chest pain but also among
other symptoms suggestive of MI, including dyspnea [4,
8]. However, STEMI is less frequent in patients with dys-
pnea than in chest pain [9]. In dyspnea, multiple other
tentative diagnoses are possible – often as interacting co-
morbid conditions [10–12]. At the same time, treatment
is often necessary before a final diagnosis is made and giv-
ing the right treatment to the right patient is a difficult
task. We therefore hypothesize that a primary complaint
of dyspnea predicts a higher mortality than chest pain in
patients suspected of MI in the ambulance.
The primary aim of the present study was to compare
mortality in telemedically triaged patients suspected of MI
presenting with dyspnea or chest pain. The secondary aim
was to compare mortality in these patients according to
whether a diagnosis of MI was established or not.
Methods
Design and setting
This is a population-based follow-up study of 23,184 tele-
medical contacts registered in the Danish Tele-database
from 1 June 2008 to 1 January 2013. The setting is the Cen-
tral Denmark Region which covers an area of 13,053 km2
of mixed urban, suburban and rural land with 1.3 million
inhabitants corresponding to 23 % of the Danish popu-
lation [13]. The EMS response in this region is two-
tiered with basic-level care delivered by ambulances
sent to all urgent cases. Anesthesiologist or nurse
anesthetist staffed prehospital critical care teams deliver
supplementary advanced prehospital care in suspected
life-threatening cases. Acutely ill patients are brought to
one of five public hospitals within the region. Revasculari-
zation therapy (percutaneous coronary intervention or
surgery) is centralized at Aarhus University Hospital.
Health care is public and provided free of charge by the
Danish National Health Service.
Ambulance personnel establish an ECG-based telemedi-
cal contact to an on-call cardiologist at a local department
of cardiology in patients suspected of an MI according to
predefined criteria: 1) patients with on-going or recent
chest pain within the past 12 h and/or clinical suspicion of
MI (e.g. pallor and diaphoresis) 2) patients with new onset
of dyspnea within the past 12 h and no known lung dis-
ease 3) patients with other symptoms raising suspicion of
heart disease (e.g. syncope/somnolence, palpitations, ab-
dominal/back pain, intoxication etc.) and 4) patients re-
suscitated from OHCA. In case of STEMI, OHCA with
no obvious non-cardiac cause, or cardiogenic shock, the
ambulance is re-routed directly to the pre-alerted
catheterization laboratory at Aarhus University Hos-
pital for coronary angiography and primary percutan-
eous coronary intervention. Patients not re-routed
directly to the catheterization laboratory are generally
admitted to the nearest hospital receiving acute pa-
tients. On-call cardiologists receiving the telemedical
calls perform all registrations in the Danish Tele-
database, including which of the above-mentioned
symptoms/conditions is the predominant cause of MI
suspicion in the individual patient.
Study population
The criterion for inclusion in the study was a registra-
tion of an ECG-based telemedical contact in the Tele-
database at a department of cardiology in the Central
Denmark Region with a valid personal identification
number. Only the first contact during the study period
in each patient was included. Participants were followed
until 9 October 2013. Contacts with invalid personal
identification number or foreigners were considered lost
to follow up and were excluded from the study.
Data sources
Vital status was retrieved from the Danish Civil Registra-
tion System; and data on previous diseases and present
diagnoses according to the 10th version of the Inter-
national Classification of Disease (ICD-10) were retrieved
from the Danish National Registry of Patients. Full med-
ical files were retrieved from a total of 200 patients with
dyspnea for development of an algorithm for determining
the cause of dyspnea in the ambulance and for validation
of this algorithm.
The present study was exempt from ethical approval
according to Danish law. The Danish Data Protection
agency (Journal nr. 1-16-02-158-12) and the Danish
Health and Medicines Authority (Journal nr. 3-3013-
247/1/) approved the study.
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Exposures and outcomes
The predominant symptoms/conditions leading to suspi-
cion of MI as registered by the on-call cardiologists were
regarded as exposures. The primary outcome was 30-day
mortality. Secondary outcomes were long-term mortality
(4 years), the number of patients in each group diag-
nosed with an MI and the associated mortality rates, and
causes of dyspnea in patients triaged because of dyspnea.
The following potential confounders were considered to
be relevant: comorbidities, age, gender, smoking status,
alcohol consumption, heart rate and systolic blood pres-
sure. Because of an expected mixture of different under-
lying diseases causing the different symptoms, we opted
on using a comorbidity index rather than adjusting for
specific diseases. We chose the Charlson Comorbidity
Index based on the ICD-10 diagnoses as described by
Sundararajan et al. as this is extensively validated - also
in a Danish population [14, 15]. Information on age,
gender, heart rate and systolic blood pressure was ob-
tained from the Tele-database. Vital signs were mea-
sured at first encounter – in patients resuscitated from
cardiac arrest immediately following ROSC. We had no
information on smoking status or alcohol consumption.
Patients diagnosed with MI were identified by ICD-10
codes ranging from DI21.0 to DI23.8A. By studying in-
formation from the full medical files from the first 100
of the 1,464 patients with dyspnea, we developed an al-
gorithm to predict the cause of dyspnea (heart disease/
lung disease/other cause) based on the ICD-10 codes
assigned at discharge (Additional file 1 and 2). A new
random sample of 100 patients from the 1464 patients
with dyspnea was then drawn to test the algorithm. For
these patients, full medical files including imaging and
blood tests were retrieved and reviewed by an end-point
adjudication committee consisting of two investigators
blinded to the result of the ICD-10 algorithm. The mem-
bers of the committee adjudicated the cause of dyspnea,
dividing it into one of three main categories: 1) heart
disease 2) lung disease and 3) other cause. In case of in-
congruence, a third investigator reviewed the material
and chose one of the two previously adjudicated causes.
Thus, the majority vote was accepted as consensus. It
was decided a priori that the performance of the ICD-10
algorithm was satisfactory if in agreement with the adjudi-
cation committee in at least 75 % of cases. This decision
was based on previously reported variations in sensitivity
and specificity in which ICD-10 codes were used to evalu-
ate whether a diagnosis of heart failure and chronic
obstructive pulmonary disease was established [16, 17].
Analyses
Mortality was displayed as Kaplan Meier curves which
were truncated when less than 10 % of the original co-
hort was left. To adjust for potential confounders, we
planned to perform a Cox proportional hazards regression
analysis. The survival curves did not fulfill the propor-
tional hazards assumption, so this plan was waived.
Instead we calculated adjusted risk differences by a gener-
alized linear regression using pseudo-observations. The
pseudo-observations approach is a transformation of data
like log-transformation and others – although it is math-
ematically more complex. In contrast to Cox regression it
allows for non-proportional survival curves and analysis
of risk differences at specific time points. It has been well
described by Klein et al. [18]. Analyses were conducted in
STATA12 (StataCorp LP, Texas, USA) according to the
Fig. 1 Study flow diagram of patients suspected of myocardial infarction triaged by use of electrocardiogram-based telemedicine
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method described by Parner and Andersen [19]. P-values
<0.05 was considered to be significant and 95 % confi-
dence intervals (CIs) were used. Participants were catego-
rized into Charlson Comorbidity Index Groups according
to the original classification by Charlson et al. [20]. Partici-
pants were categorized according to systolic blood pres-
sure and heart rate into four groups approximated to
quartiles. Missing data were expected to be missing com-
pletely at random and no imputation was made.
Results
Of 23,184 telemedical contacts, 17,398 correct regis-
trations of first telemedical contacts in individual pa-
tients were included (Fig. 1). The patients’ baseline
characteristics are presented in Table 1. Median
follow-up time was 2.4 years (IQR: 1.3 – 3.7). An MI
was diagnosed in 2319 of 12,230 (19 %) patients with
chest pain and in 121 of 1464 (8.3 %) patients with
dyspnea. Patients suffering dyspnea had higher mortal-
ity rates than patients with chest pain at both day 30
(primary endpoint) and 4 years, irrespective of whether
a diagnosis of MI was confirmed or not (Table 2).
Kaplan-Meier estimates for mortality in all four groups
of patients are displayed in Fig. 2. Kaplan-Meier esti-
mates for mortality in patients with chest pain and
dyspnea with and without confirmed MI are displayed
in Fig. 3. Age, comorbidity, systolic blood pressure and
heart rate remained significant predictors of mortality
in the generalized linear regression model. Adjusted
for these potential confounders, patients suffering dys-
pnea still had higher mortality rates than patients suf-
fering chest pain (Table 3).
Table 1 Baseline characteristics for patients suspected of myocardial infarction triaged by use of electrocardiogram-based
telemedicine (n = 17,398). Stratified according to symptom/condition leading to telemedical triage
Chest pain Dyspnea Cardiac arrest Other
(n = 12,230) (n = 1464) (n = 164) (n = 3540)
Variables No (%) Valid cases No (%) Valid cases No (%) Valid cases No (%) Valid cases p
Demographics
Age, median (IQR), y 65 (53–76) 12,230 76 (65–84) 1464 67 (57–79) 163 71 (59–81) 3540 <0.001
Sex (male) 7061 (58) 12,230 760 (52) 1464 114 (70) 163 2098 (59) 3540 <0.001
Charlson comorbidity
index group
12,230 1464 163 3540
0 6296 (51) 483 (33) 90 (55) 1638 (46) <0.001
1–2 4016 (33) 517 (35) 57 (35) 1235 (35) <0.001
3–4 1274 (10) 279 (19) 11 (7) 441 (12) <0.001





146 (129–166) 11,449 148 (128–170) 1362 129 (107–148) 124 138 (120–158) 3240 <0.001
Diastolic, median (IQR),
mmHg
88 (77–99) 11,411 87 (74–102) 1361 83 (66–102) 123 82 (70–94) 3231 <0.001
Heart Rate, median (IQR),
beats/min
82 (70–98) 11,451 95 (80–116) 1373 92 (76–105) 127 82 (67–101) 3242 <0.001
Binary data are compared using chi-squared test, continuous data are compared using Kruskal Wallis test
Table 2 Crude mortality rates in patients suspected of myocardial infarction triaged by use of electrocardiogram-based telemedicine
(n = 17,398). Stratified according to symptom/condition leading to telemedical triage and to myocardial infarction diagnosis in
patients with dyspnea and chest pain
Chest pain (n = 12,230) Dyspnea (n = 1464) Cardiac arrest (n = 164) Other (n = 3540)
Overall No MI MI Overall No MI MI
Mortality (n = 12,230) (n = 9911) (n = 2319) (n = 1464) (n = 1343) (n = 121)
30 days
(95% CI)
2.9 % (2.6–3.2) 2.3 % (2.1–2.7) 5.0 % (4.2–5.8) 13 % (12–15) 13 % (11–15) 21 % (15–30) 38 % (31–46) 5.8 % (5.0–6.6)
4 years 95% CI 20 % (19–21) 19 % (18–20) 23 % (21–25) 50 % (47–54) 50 % (46–53) 60 % (50–70) 51 % (42–60) 29 % (27–31)
Abbreviations: MI myocardial infarction
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Cause of dyspnea
Two endpoint committee adjudicators agreed on the pri-
mary cause of dyspnea in all but four of 100 patients
sampled for validation. In these patients, the third adju-
dicator was involved and the majority vote was accepted.
The ICD-10 diagnosis algorithm was in agreement with
the endpoint adjudication committee in 78 % of the 100
patients sampled for validation. The predominant under-
lying cause of dyspnea in this cohort of patients sus-
pected of MI was heart disease, but only 8,3 % actually
had an MI (Table 4). Among patients in whom heart dis-
ease was the primary cause of dyspnea, 20 % were also
Fig. 2 Kaplan Meier curves of cumulative mortality in patients suspected of myocardial infarction triaged by use of electrocardiogram-
based telemedicine (n = 17,398). Stratified according to symptom/condition leading to telemedical triage
Fig. 3 Kaplan Meier curves of cumulative mortality in patients with dyspnea and chest pain suspected of myocardial infarction and triaged by
use of electrocardiogram-based telemedicine (n = 13,694). Stratified according to whether a myocardial infarction was diagnosed or not
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diagnosed with a lung disease. When lung disease was
the primary cause for dyspnea, 41 % of patients were
also diagnosed with a heart disease.
Sensitivity analyses
We performed three sensitivity analyses, all related to
different ways of adjusting for age and comorbidity (in-
cluded in Additional file 3). We accounted for a possible
higher risk with increasing age in older age categories
than in younger by including both age and age squared
and for a possible polynomial development by including
age as qubic splines with seven knots. This reduced the
effect of dyspnea slightly but did not change the overall
patterns. Including specific diseases related to chest pain
and dyspnea rather than the Charlson Comorbidity
Index in addition to using qubic splines to adjust for age
did not change the results.
Discussion
This study demonstrates that among patients suspected
of MI in the ambulance, patients presenting dyspnea
have a three-fold higher mortality than patients with
chest pain irrespective of a confirmation of the MI diag-
nosis. Adjustment for potential confounders does not
change these patterns.
Dyspnea vs. other symptoms
Studies comparing mortality rates in patients with dys-
pnea and patients with other symptoms in a prehospital
setting are scarce. However, a large study in emergency
medical technician witnessed OHCA showed that
Table 3 Generalized linear regression analysis of covariates associated with mortality. Analyzed at 30 days and 4 years in patients
suspected of myocardial infarction triaged by use of electrocardiogram-based telemedicine (n = 15,578 cases with complete data)
30-day mortality 4-year mortality
Covariates remaining
significant in models Risk difference (95 % CI) P value Risk difference (95 % CI) P value
Demographics
Age, per 1-y increase 0.19 % (0.17 to 0.21) <0.001 0.9 % (0.8 to 1.0)) <0.001
Comorbidity
Charlson Comorbidity Index
0 1 [Reference] 1 [Reference]
1–2 0.1 % (−0.6 to 0.8) 0.852 7.2 % (5.4 to 8.9) <0.001
3–4 1.6 % (0.3 to 2.8) 0.017 22 % (19 to 26) <0.001
≥5 6.4 % (4.3 to 8.6) <0.001 39 % (35 to 44) <0.001
Clinical characteristics
Systolic blood pressure
<120 1 [Reference] 1 [Reference]
120–139 −4.9 % (−6.2 to −3.6) <0.001 −3.7 % (−6.2 to −1.2) 0.004
140–159 −6.0 % (−7.3 to −4.8) <0.001 −7.3 % (−9.9 to −4.8) <0.001
≥160 −7.8 % (−9.1 to −6.5) <0.001 −11 % (−13 to −8.0) <0.001
Heart rate
<70 1 [Reference] 1 [Reference]
70–84 1.3 % (0.5 to 2.1) 0.001 4.1 % (2.0 to 6.3) <0.001
85–99 2.2 % (1.3 to 3.1) <0.001 5.2 % (2.9 to 7.5) <0.001
≥100 3.2 % (2.2 to 4.1) <0.001 8.7 % (6.5 to 10.9) <0.001
Patient category
Chest pain, no MI 1 [Reference] 1 [Reference]
Chest pain and MI 1.8 % (0.8 to 2.8) <0.001 1.7 % (−0.7 to 4.0) 0.167
Dyspnea, no MI 7.3 % (5.5 to 9.2) <0.001 16 % (12 to 19) <0.001
Dyspnea and MI 12 % (5.7 to 20) <0.001 21 % (11 to 32) <0.001
Other 1.7 % (0.8 to 2.6) <0.001 3.8 % (1.7 to 5.8) <0.001
Cardiac arrest 26 % (18 to 34) <0.001 20 % (11 to 29) <0.001
Abbreviations: MI myocardial infarction
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patients suffering chest pain prior to cardiac arrest were
five times more likely to survive than patients suffering
dyspnea prior to cardiac arrest [21]. In a retrospective
analysis of hospitalized patients with first-time MI, dys-
pnea was associated with higher long-term mortality
than other presenting symptoms, including chest pain
[22]. In patients undergoing coronary angiography for
suspected acute coronary syndrome, a four-fold higher
mortality in dyspneic compared to non-dyspneic patients
was demonstrated [23]. Thus, the observation of higher
mortality among dyspneic patients is consistent across
the prehospital setting, the acute hospital setting, and
the catheterization laboratory. Nevertheless, we still do
not have broadly accepted guidelines for management of
the dyspneic patient in the prehospital setting.
Diagnoses, comorbidities and age
Approximately 8 % of the patients suffering dyspnea had
an MI. ECG acquisition is thus important also in
prehospital diagnostics in dyspnea patients, but it seems
inadequate to establish a prehospital diagnosis and iden-
tify high-risk patients in this patient group in general.
These patients suffer from a variety of diseases not only
including MI but also heart failure, pulmonary infec-
tions, and obstructive pulmonary disorders. Further-
more, our study also demonstrates that heart and lung
disease frequently coexist. This is supported by other
studies [11, 12], and this co-existence deteriorates the
prognosis [10]. As it is seen from Table 1, age and
comorbidities do play a major role in the high mortality
in patients with dyspnea. At long term, the independent
effect on mortality of being in CCI group ≥ 3 or being
10 years older is more pronounced than the effect of
suffering dyspnea. At short term, the same applies to
age, but not comorbidities. In addition, no matter how
we tried to adjust for age and comorbidities, we were
not able to eliminate an independent effect of dyspnea
compared to chest pain. This indicates, that there is a
potential for improving care of patients with dyspnea.
Based on the very high mortality observed in the first
short period of time after ambulance contact, there
seems to be a window of opportunity in the acute phase
(refer to the Kaplan-Meier curves in Fig. 2).
Towards a systematic approach
As of now, a stethoscope and an ECG is the most ad-
vanced diagnostics routinely used in dyspneic patients in
the prehospital setting. Treatment is often broad rather
than specific and the evidence behind different new
interventions is scarce. We are currently witnessing sev-
eral, promising technological developments that may aid
prehospital decision-making and treatment in dyspneic
patients. Point-of-care testing with biomarkers, like brain
natriuretic peptides and focused ultrasonography, has
been suggested [24–26]. Establishing an accurate diagno-
sis already in the ambulance to facilitate earlier correct
therapy and triage high-risk patients to specialized de-
partments or intensive care unit may improve outcome,
but this has not been examined. New treatment regimes
facilitating oxygenation and ventilation by continuous
positive airway pressure or non-invasive ventilation has
also been suggested, but has not been sufficiently exam-
ined in relation to patient outcome [27]. Validating the
findings of this study in unselected patients with dys-
pnea in the prehospital setting and the systematic use of
prehospital point-of-care diagnostics and novel treat-
ments for this patient group are potential subjects for
future research.
Strengths and limitations
A high number of consecutively registered patients and
adjustment for major confounding factors including age
and comorbidity are strengths of this study. Unlike most
Table 4 Diagnoses in patients with dyspnea. Primary diagnoses
in patients suspected of myocardial infarction because of dyspnea
and triaged by use of electrocardiogram-based telemedicine
(n = 1464)
Primary diagnosis n (%)
Heart disease 692 (47.3)
Heart failure/cardiomyopathies 202 (13.8)
Supraventricular tachycardia 151 (10.3)
Acute myocardial infarction 121 (8.3)
Pulmonary embolism 64 (4.4)
Chronic ischaemic heart disease 57 (4.0)
Valvular heart disease 46 (3.2)
Other arrhythmia 17 (1.2)
Other heart disease 34 (2.3)
Lung disease 359 (24.5)
Pulmonary infections 209 (14.3)
Obstructive lung diseases 121 (8.3)
Pleural disorders 12 (0.8)
Interstitial lung disease 8 (0.6)
Other lung diseases 9 (0.6)
Other 413 (28.2)
Other infections 49 (3.4)
Gastrointestinal diseases 31 (2.1)
Endocrine and metabolic diseases 26 (1.8)
Anaemia 18 (1.2)
Renal disease 18 (1.2)
Miscellaneous 133 (9.1)
No final diagnosis 138 (9.4)
Symptom/“encounter for” diagnoses 105 (7.1)
No hospital admission 33 (2.3)
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epidemiological studies, we were also able to adjust for
prehospital values of systolic blood pressure and heart
rate. An endpoint-adjudication committee validated the
use of ICD-10 diagnoses to establish the cause of dys-
pnea. Owing to the predefined criteria for telemedical
contact, only a fraction of all patients with dyspnea in
the ambulance were telemedically triaged and registered.
A selection bias that favors a higher proportion of pa-
tients with heart disease is evident. Dyspneic patients
suspected of MI might be more severely affected than
those not suspected of MI because some of them may
have large anterior infarctions and non-cardiac acute
conditions like pulmonary embolism and pneumothorax.
This might have led to an overestimation of the mortal-
ity in patients with dyspnea compared with a general
prehospital dyspnea population. As we did not have data
on smoking status, alcohol consumption, left ventricular
systolic function or pulmonary function, residual con-
founding might be present. However, adjusting for
smoking status did not change the association between
dyspnea and mortality in several other studies [7, 28].
Pulmonary disease and heart failure are included in the
Charlson Comorbidity Index and adjustment was inher-
ent for pulmonary function and left ventricular systolic
function.
Conclusion
Patients suspected of MI presenting with dyspnea have
a markedly higher short- and long-term mortality than
patients with chest pain irrespective of the presence of
MI. ECG acquisition and interpretation are insufficient
to diagnose such high-risk patients in this group. Further
studies are needed to clarify whether supplementary
prehospital diagnostics can improve triage, facilitate earlier
correct therapy and improve outcome in patients pre-
senting with dyspnea.
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